New Key Statistics Module, Z-Score and F-Score
XCNQ:XTCY Key Ratios
Market Cap C$ M | 2.18 |
Enterprise Value C$ M | 2.21 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 50.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.01 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -3.80 |
5-y EBITDA Growth Rate % | 38.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.64 |
EV-to-EBITDA | -2.64 |
PEG | -- |
Shares Outstanding M | 54.58 |
Net Margin (%) | -947.83 |
Operating Margin % | -1,821.74 |
Pre-tax Margin (%) | -947.83 |
Quick Ratio | 0.22 |
Current Ratio | 0.22 |
ROA % (ttm) | -159.36 |
ROE % (ttm) | -- |
ROIC % (ttm) | -316.23 |
Dividend Yield % | -- |
Altman Z-Score | -138.28 |
XCNQ:XTCY Number of Guru Trades
XCNQ:XTCY Volume of Guru Trades
Gurus Latest Trades with XCNQ:XTCY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:XTCY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xtacy Therapeutics Corp Insider Transactions
No Available Data